Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Ongoing research and innovation are crucial for improving skin care and treatment.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alopecia areata treatment varies, with no optimal method established yet.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Upadacitinib may cause hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Human hair follicles have a scent receptor that can influence hair growth.

Tofacitinib is effective and safe for treating severe alopecia areata.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

NF-κB is crucial for zebrafish heart repair, affecting heart cell growth and repair processes.

Blocking IL-17 signaling may reduce skin inflammation and delay aging.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.